Mateos, M., & San Miguel, J. F. (2012). Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myeloma. SAGE Publications.
Παραπομπή Chicago StyleMateos, Marìa-Victoria, και Jesús F. San Miguel. Safety and Efficacy of Subcutaneous Formulation of Bortezomib Versus the Conventional Intravenous Formulation in Multiple Myeloma. SAGE Publications, 2012.
Παραπομπή MLAMateos, Marìa-Victoria, και Jesús F. San Miguel. Safety and Efficacy of Subcutaneous Formulation of Bortezomib Versus the Conventional Intravenous Formulation in Multiple Myeloma. SAGE Publications, 2012.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.